BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 1533159)

  • 21. Structural features of the first component of human complement, C1, as revealed by surface iodination.
    Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
    Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
    Bauer J; Valet G
    Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure and function of the serine-protease subcomponents of C1: protein engineering studies.
    Gál P; Závodszky P
    Immunobiology; 1998 Aug; 199(2):317-26. PubMed ID: 9777415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of human C1q by combined bottom-up and top-down mass spectrometry: detailed mapping of post-translational modifications and insights into the C1r/C1s binding sites.
    Pflieger D; Przybylski C; Gonnet F; Le Caer JP; Lunardi T; Arlaud GJ; Daniel R
    Mol Cell Proteomics; 2010 Apr; 9(4):593-610. PubMed ID: 20008834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of purified C1 subcomponents, C1 inactivator and their complexes to immobilized heparin.
    McKay EJ; Johnson U; Laurell AB; Mårtensson U; Sjöholm AG
    Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):339-44. PubMed ID: 6274149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
    Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
    J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19.
    Thiel S; Petersen SV; Vorup-Jensen T; Matsushita M; Fujita T; Stover CM; Schwaeble WJ; Jensenius JC
    J Immunol; 2000 Jul; 165(2):878-87. PubMed ID: 10878362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol Methods; 1990 May; 129(1):55-61. PubMed ID: 2338498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A molecular mechanism for the activation of the first component of complement by immune complexes.
    Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
    Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical and functional characterization of a fragment of C1-s containing the epidermal growth factor homology region.
    Thielens NM; Van Dorsselaer A; Gagnon J; Arlaud GJ
    Biochemistry; 1990 Apr; 29(14):3570-8. PubMed ID: 2141278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional model of subcomponent C1 of human complement.
    Weiss V; Fauser C; Engel J
    J Mol Biol; 1986 Jun; 189(3):573-81. PubMed ID: 3023630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assembly of the C1 complex.
    Arlaud GJ; Thielens NM; Illy C
    Behring Inst Mitt; 1993 Dec; (93):189-95. PubMed ID: 8172567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The unactivated form of the first component of human complement, C1.
    Gigli I; Porter RR; Sim RB
    Biochem J; 1976 Sep; 157(3):541-8. PubMed ID: 985398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional analysis of the serpin domain of C1 inhibitor.
    Coutinho M; Aulak KS; Davis AE
    J Immunol; 1994 Oct; 153(8):3648-54. PubMed ID: 7930585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosynthesis of the subcomponents C1q, C1r and C1s of the first component of complement (C1) by guinea pig hepatocyte primary cultures.
    Ramadori G; Heinz HP; Martin H; Meyer zum Büschenfelde KH; Loos M
    Eur J Immunol; 1986 Sep; 16(9):1137-41. PubMed ID: 3019707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Models for C1. Tools or toys? The real biological challenge.
    Colomb MG; Arlaud GJ; Chesne S
    Behring Inst Mitt; 1989 Jul; (84):121-8. PubMed ID: 2552979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of macromolecular interactions between complement subcomponents C1q, C1r, C1s, and immunoglobulin IgM by sedimentation analysis using the analytical ultracentrifuge.
    Poon PH; Schumaker VN
    J Biol Chem; 1991 Mar; 266(9):5723-7. PubMed ID: 2005109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.